Canadian Public Health Association
The Canadian Public Health Association (CPHA) is a non-governmental organization (NGO) that “advises[s] decision-makers about public health system reform and to guide initiatives to help safeguard the personal and community health of Canadians and people around the world.”1)
Academic Journal
The CPHA publishes the Canadian Journal of Public Health, which “aims to advance public health research and practice in Canada and around the world, contributing to the improvement of the health of populations and the reduction of health inequalities.”2) Its Editor-in-Chief is Louise Potvin. The Journal is a member of the Committee on Publication Ethics (COPE).3)
In its 2020 Annual Report, the CPHA reported revenue from the journal of $89,799.00 and expenses of $76,339.00, for a profit of $13,460.00.4) It made an additional $30,905.00 in revenue from Publication Sales with $25,770.00 in expenses, for a profit of $5,135.00. If these two are combined, the journal made a net profit of $18,595.00 in 2020.
Funding and Partnerships
Despite claims of independence, the CPHA is funded by groups that cause substantial potentical conflicts of interest including pharmaceutical companies, government agencies, and academic institutions.5) 6) 7) 8) 9) 10) 11) 12) 13) 14)
Academia
The CPHA receives funding from the following academic institutions:
- Concordia University College of Alberta: Department of Public Health
- Lakehead University: Department of Health Sciences
- University of Alberta: School of Public Health
- University of Lethbridge: Faculty of Health Sciences
- University of Toronto: Dalla Lana School of Public Health
- University of Waterloo: School of Public Health and Health Systems
- University of Western Ontario: Schulich Interfaculty Program in Public Health
Government
Federal
The CPHA receives funding from their “benefactors” in the Canadian federal government through the following funding bodies:
In its 2020 Annual Report, the CPHA reported receiving $518,471.00 from the Canada Emergency Wage Subsidy fund.
Provincial
Alberta
British Columbia
Ontario
Québec
Regional
Alberta
British Columbia
Healthcare
- Nouveau Départ (EHN Canada)
Insurance Companies
Non-Governmental Organizations (NGOs)
In their annual reports over the last decade, the CPHA lists funding from the following “Supporters of Public Health in Canada”, “Collaborators”, and related descriptors:
Pharmaceutical Companies
The CPHA receives financial support from all of the major pharmaceutical companies with a stake in the COVID-19 crisis, either directly or through aggregates:
- BIOTECanada - Vaccine Industry Committee. Aggregated group of pharmaceutical companies.15)
- Innovative Medicines Canada - Formerly named Canada’s Research-Based Pharmaceutical Companies (Rx&D). Aggregated group of pharmaceutical companies.17)
- Johnson & Johnson - Through the parent company as well as Janssen, their pharmaceutical arm.
- VBI Vaccines - Developing a COVID-19 vaccine product with the Coalition for Epidemic Preparedness Innovations (CEPI).18) 19)
- VIDO-Intervac - Based at the University of Saskatchewan. Developing a “variant-proof” COVID-19 vaccine product with CEPI.20) 21) Partnered with South China Vaccine Co. Ltd. at Guangzhou Science City in the People's Republic of China.22) Receives funding from the Guangzhou Institute of Respiratory Disease and Guangzhou Yuanbo Medical Technology Company.23)
Supra-national Organizations
Some funding for the CPHA comes from outside Canada's borders from international interests:
Projects and Conferences
In its 2020 Annual report, the CPHA revealed that its revenue and expenses related to “Projects and Conferences” was identical at $2,924,754.00, for a net profit of $0.
CANVax
The CPHA funds a project called The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax), an “online database of curated resources to support immunization program planning and promotional activities to improve vaccine acceptance and uptake in Canada.”24)